Do gender, age or lifestyle factors affect responses to antimuscarinic treatment in overactive bladder patients?

Abstract

We conclude that the efficacy and tolerability of a muscarinic receptor antagonist, such as darifenacin is largely independent of potential OAB risk factors, such as gender, age, obesity, smoking and alcohol or caffeine intake.